Results for tag: "Transplant Rejection"

The Transplant Rejection market is a subset of the Allergy and Immunology field, which focuses on the body's immune response to foreign substances. Transplant rejection occurs when the body's immune system recognizes a transplanted organ as foreign and attacks it. This can lead to organ failure and death. To prevent this, immunosuppressive drugs are used to suppress the body's immune response and reduce the risk of rejection. These drugs are typically used in combination with other treatments, such as tissue typing and immunosuppressive therapy. The Transplant Rejection market is a growing field, with a variety of treatments and therapies available. Companies in this market include Novartis, Pfizer, Merck, and Astellas Pharma. Show Less Read more